首页> 外文期刊>Inorganica Chimica Acta >(Pyrazolylmethyl)pyridine platinum(II) and gold(III) complexes: Synthesis, structures and evaluation as anticancer agents
【24h】

(Pyrazolylmethyl)pyridine platinum(II) and gold(III) complexes: Synthesis, structures and evaluation as anticancer agents

机译:(吡唑基甲基)吡啶铂(II)和金(III)配合物:合成,结构和评价作为抗癌药

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Reactions of 2-(3,5-dimethylpyrazol-1-ylmethyl)pyridine (L1), 2-(3,5-diphenylpyrazol-1-ylmethyl)pyri_dine (12), 2-(3,5-di-tert-butylpyrazol-1-ylmethyl)pyridine (L3) and 2-(3 -p-tolylpyrazol-1 -ylmethyl )pyri_dine (IA) with K_2[PtC1_4] in a mixture of ethanol and water formed the dichloro platinum complexes [PtC1_2(Ll)] (1), [PtC1_2(L2)] (2), [PtCl_2(L3)1(3) and [PtCl_2(L4)1(4). Complex 1, [PtCl_2(L1)], could also be pre_pared in a mixture of acetone and water. Performing the reactions of L2 and L3 in a mixture of acetone and water, however, led to C-H activation of acetone under mild conditions to form the neutral acetonyl complexes [Pt(CH_2C00H_3)CI(L2)] (2a) and [Pt(CH_20OCH_3)Cl(L3)] (3a). The same ligands reacted with HAuCI_4 4H_2O in a mixture of ethanol and water to form the gold salts [AuC1_2(Ll)][AuC1_4] (5) [AuC1_2(L2)][CI] (6) [AuC1_2(L3)][CI] (7) and [AuC1_2(L4)][AuC1_41 (8); however, with the pyrazolyl unit in the para position of the pyridinyl ring in 4-(3,5-dimethylpyrazol-1-ylmethyl)pyridine (LS), 4-(3,5-diph_enylpyrazol-1-ylmethyl)pyridine (L6) neutral gold complexes [AuCl_3(L5)] (9) and [AuCl_2(L6)] (10) were formed; signifying the role the position of the pyrazolyl group plays in product formation in the gold reactions. X-ray crystallographic structural determination of L6, 2, 3 3a, 8 and 10 were very important in confirming the structures of these compounds; particularly for 3a and 8 where the presence of the acetonyl group confirmed C-H activation and for 8 where the counter ion is AuCI_4~-. Cytotoxicity studies of 12, L4 and complexes 1-10 against HeLa cells showed the Au complexes were much less active than the Pt complexes.
机译:2-(3,5-二甲基吡唑-1-基甲基)吡啶(L1),2-(3,5-二苯基吡唑-1-基甲基)吡啶_丁(12),2-(3,5-二叔丁基吡唑)的反应在乙醇和水的混合物中,具有K_2 [PtC1_4]的-1-基甲基)吡啶(L3)和2-(3-对甲苯基吡唑-1-基甲基)吡啶_二胺(IA)形成二氯铂配合物[PtC1_2(Ll)] (1),[PtC1_2(L2)](2),[PtCl_2(L3)1(3)和[PtCl_2(L4)1(4)。络合物1,[PtCl_2(L1)],也可以在丙酮和水的混合物中制备。但是,在丙酮和水的混合物中进行L2和L3的反应会导致在温和条件下CH活化丙酮,从而形成中性丙酮基络合物[Pt(CH_2C00H_3)CI(L2)](2a)和[Pt(CH_20OCH_3) )Cl(L3)](3a)。相同的配体在乙醇和水的混合物中与HAuCI_4 4H_2O反应形成金盐[AuC1_2(L1)] [AuC1_4](5)[AuC1_2(L2)] [CI](6)[AuC1_2(L3)] [ CI](7)和[AuC1_2(L4)] [AuC1_41(8);然而,吡唑基单元在4-(3,5-二甲基吡唑-1-基甲基)吡啶(LS),4-(3,5-二苯基吡唑-1-基甲基)吡啶(L6)的吡啶基环的对位形成中性金络合物[AuCl_3(L5)](9)和[AuCl_2(L6)](10);表明吡唑基的位置在金反应中起产物形成的作用。 L6、2、3、3a,8和10的X射线晶体学结构测定对确定这些化合物的结构非常重要;特别是对于3a和8,其中丙酮基的存在证实了C-H活化,对于8,其中抗衡离子是AuCl 4-。对HeLa细胞进行的12,L4和1-10复合物的细胞毒性研究表明,Au复合物的活性远低于Pt复合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号